Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prescribing information in 26 countries: a comparative study.

V Reggi1, R Balocco-Mattavelli, M Bonati

  • 1Quality assurance and safety: medicines, World Health Organization, Geneva, Switzerland.

European Journal of Clinical Pharmacology
|May 22, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of acute lymphopenia after radiotherapy for prostate cancer including pelvic node irradiation: results of a real-world prospective multi-centric study.

ESMO real world data and digital oncology·2026
Same author

[One hundred «not to do» recommendations in the clinical care of people with obesity].

Semergen·2026
Same author

Compartment-specific immune response in Mytilus galloprovincialis to Vibrio splendidus revealed by haemolymph proteomics.

Fish & shellfish immunology·2025
Same author

Comparative transcriptomics reveals different grades of susceptibility to a bacterial infection in bivalves.

Fish & shellfish immunology·2025
Same author

Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.

Frontiers in pharmacology·2024
Same author

Spontaneous adverse drug reactions reported in a thirteen-year pharmacovigilance program in a tertiary university hospital.

Frontiers in pharmacology·2024
Same journal

Efficacy and safety of Ensitrelvir in COVID-19 patients: a systematic review and meta-analysis with focus on viral clearance and RNA change.

European journal of clinical pharmacology·2026
Same journal

Comparing National Health Technology Assessment approaches and the new European Joint Clinical Assessment framework: The case of onco-hematological medicines.

European journal of clinical pharmacology·2026
Same journal

The efficacy of letrozole in the medical management of ectopic pregnancy: a systematic review and meta-analysis.

European journal of clinical pharmacology·2026
Same journal

Detection of intravenous drug physicochemical incompatibilities in clinical practice: e-Harvis compared to reference tools.

European journal of clinical pharmacology·2026
Same journal

Efficacy and safety of doravirine/islatravir for the treatment of HIV-1: a systematic review and meta-analysis of randomized controlled trials with GRADE assessment.

European journal of clinical pharmacology·2026
Same journal

Critical analysis of digitalis glycosides: declining use but increasing poison-center exposure cases for digitoxin.

European journal of clinical pharmacology·2026
See all related articles

Prescribing information for drugs varies significantly across countries and even brands, potentially misleading healthcare providers and patients. Regulatory authorities must improve international collaboration and standardize drug information to ensure accuracy and patient safety.

Area of Science:

  • Pharmacovigilance
  • Drug Regulation
  • Health Communication

Background:

  • Prescribing information is crucial for safe and effective medication use.
  • Variability in drug information can arise from different regulatory assessments and commercial influences.
  • Discrepancies in drug details may impact clinical decision-making and patient understanding.

Purpose of the Study:

  • To document and quantify variability in drug prescribing information across different sources and countries.
  • To develop a method for assessing agreement in drug information.
  • To identify implications of information discrepancies for prescribers, patients, and comparative drug-use studies.

Main Methods:

  • Development of an original method to measure information agreement.

Related Experiment Videos

  • Comparison of drug information from various sources: Summaries of Product Characteristics (SmPCs), package inserts, data sheets, and a reference text.
  • Analysis of information for selected drugs across different countries and brands within countries.

    • Main Results:

    • Substantial disagreement found in drug information available to prescribers and patients globally.
    • Significant discordance observed even between different brands of the same drug within a single country.
    • Variability attributed to differing national assessments of available drug evidence.

    Conclusions:

    • Discrepancies in drug information pose a risk of misleading healthcare professionals and patients.
    • National regulatory authorities must enhance international collaboration and standardize drug information materials.
    • Implementing measures to remove contradictory statements and providing training for regulatory officials are essential for reliable, independent drug information.